Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Abbott is also recipient of Prix Galien for its protease inhibitor

Feb. 17, 1999

Agouron presents Women First study results at ROI conference

Feb. 16, 1999

U.S. university researchers claim anti-HIV 2',5'-phosphorothioate/phosphodiester oligoadenylates

Feb. 15, 1999

Protease inhibitors awarded 1998 Prix Galien

Feb. 15, 1999

SIV isolates from chimpanzees closely related to HIV-1

Feb. 15, 1999

Pediatric study supports use of vCP205 in infants born to HIV-positive mothers

Feb. 12, 1999

T-140, a potent CXCR4-dependent inhibitor of HIV infection

Feb. 12, 1999

Glaxo presents new NNRTI from quinoxaline class that has progressed to human trials

Feb. 12, 1999

Steroidogenesis Inhibitors to begin satellite open clinical studies in multiple indications

Feb. 12, 1999

Sarawak MediChem's calanolide compounds featured at ROI conference

Feb. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...